Authors:
Lazarus, SC
Boushey, HA
Fahy, JV
Chinchilli, VM
Lemanske, RF
Sorkness, CA
Kraft, M
Fish, JE
Peters, SP
Craig, T
Drazen, JM
Ford, JG
Israel, E
Martin, RJ
Mauger, EA
Nachman, SA
Spahn, JD
Szefler, SJ
Citation: Sc. Lazarus et al., Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2583-2593
Authors:
Lemanske, RF
Sorkness, CA
Mauger, EA
Lazarus, SC
Boushey, HA
Fahy, JV
Drazen, JM
Chinchilli, VM
Craig, T
Fish, JE
Ford, JG
Israel, E
Kraft, M
Martin, RJ
Nachman, SA
Peters, SP
Spahn, JD
Szefler, SJ
Citation: Rf. Lemanske et al., Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2594-2603
Authors:
Cover, RA
Leung, DYM
McCormick, D
Steelman, J
Zeitler, P
Spahn, JD
Citation: Ra. Cover et al., Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma, J ALLERG CL, 106(4), 2000, pp. 651-659
Authors:
Fost, DA
Leung, DYM
Martin, RJ
Brown, EE
Szefler, SJ
Spahn, JD
Citation: Da. Fost et al., Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy, J ALLERG CL, 103(6), 1999, pp. 1031-1035
Citation: Jd. Spahn et al., Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin, J ALLERG CL, 103(3), 1999, pp. 421-426